Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/10/2013 | 02:09pm CET

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
07:55p ATLANTIC CANADA : working together to reduce red tape
07:55p U S DEPARTMENT OF DEFENSE : Counter-ISIL Strikes Target Terrorists in Syria, Iraq
07:55p BONITA SPRINGS AREA CHAMBER OF COMMERCE : Premier Commercial, Inc Week of January 16 – January 20, 2017 Sales and Leasing News
07:55p UNITED CITY OF YORKVILLE IL : ComEd Smart Meters are Coming to Yorkville
07:54p EXXON MOBIL : Cardin Statement on Tillerson Vote
07:54p CONTINENTAL : Global Automotive Brake Master Cylinder Market 2017 - Bosch, Continental AG, TRW, ACDelco, Aisin, Berger Holding, Mando, Meritor Wabco, Cifam
07:53p U.S. blocks health insurer Aetna's $34 billion Humana acquisition
07:53pDJBOND REPORT : Treasury Yields On Track For Largest Decline In More Than 2 Weeks
07:53p TAX SEASON HAS OFFICIALLY BEGUN : Time to Claim Those Tax Deductions Before They Go Away
07:52p Trump pulls U.S. out of Pacific trade deal, loosening Asia ties
Latest news
Advertisement
Hot News 
-2.34%AETNA : Federal Judge Blocks Aetna-Humana Merger on Antitrust Grounds
-2.72%PHILIPS LIGHTING : sees brighter 2017 as fourth-quarter profit disappoints
-2.58%U.S. auto parts sellers skid after report on Amazon's entry
-7.16%LAMPRELL : Rig builder Lamprell sees lower revenue, tightens purse strings
-1.13%European shares close at lowest in three weeks as banks, Fingerprint Cards fall
Most Read News
11:57a Dollar, world stocks slide on Trump's protectionist stance
04:07a SAMSUNG ELECTRONICS : says batteries caused Note 7 fires, may delay new phone launch
01:30p MCDONALD : U.S. restaurant sales fall after five quarters of gains
12:23pDJUNITED TECHNOLOGIES : Correction to 'Trump Promises Very Major Border Tax on Outsourcing Companies'
09:35a TRUMP TO COMPANY EXECUTIVES : We think we can cut regulations by 75 percent
Most recommended articles
01/17DJS&P 500, Nasdaq Futures -- Technical Analysis
01:53p U.S. blocks health insurer Aetna's $34 billion Humana acquisition
01:46pDJBERKSHIRE HATHAWAY : Unit Buys German Pipe Component Maker
01:43p ANDREW LIVERIS : Liveris
01:40p CITI SUBSIDIARIES TO PAY $28.8 MILLION OVER GIVING U.S. HOMEOWNERS 'RUNAROUND' : Cfpb